JB Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2M Buy
198,688
+52,378
+36% +$5.02M 0.7% 33
2025
Q4
$14.1M Buy
146,310
+8,695
+6% +$845K 0.57% 32
2025
Q3
$13.1M Buy
137,615
+10,152
+8% +$933K 0.57% 31
2025
Q2
$11.1M Buy
127,463
+6,515
+5% +$553K 0.54% 33
2025
Q1
$10.9M Buy
120,948
+4,071
+3% +$364K 0.6% 30
2024
Q4
$9.34M Buy
116,877
+6,381
+6% +$552K 0.52% 33
2024
Q3
$9.95M Buy
110,496
+5,083
+5% +$428K 0.57% 30
2024
Q2
$8.3M Buy
105,413
+5,908
+6% +$484K 0.52% 35
2024
Q1
$8.67M Buy
99,505
+9,452
+10% +$807K 0.58% 34
2023
Q4
$7.42M Buy
90,053
+10,177
+13% +$776K 0.55% 35
2023
Q3
$6.26M Buy
79,876
+14,464
+22% +$1.21M 0.53% 34
2023
Q2
$5.76M Buy
65,412
+3,259
+5% +$281K 0.49% 35
2023
Q1
$5.01M Buy
62,153
+1,748
+3% +$142K 0.46% 36
2022
Q4
$4.69M Buy
60,405
+3,944
+7% +$320K 0.46% 47
2022
Q3
$4.56M Buy
+56,461
New +$5.07M 0.5% 37

Other funds holding MDT

JB Capital's MDT Position: Q1 2026 in Review

JB Capital increased its Medtronic (MDT) stake by 36% in Q1 2026, buying an estimated $5.02M and bringing the position to 198,688 shares worth $17.2M. The position accounts for 0.7% of the portfolio, ranked #33.

JB Capital first reported a position in MDT in Q3 2022 and has held it in 15 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • JB Capital held 198,688 shares of Medtronic worth $17.2M as of Q1 2026.
  • JB Capital bought 52,378 Medtronic shares in Q1 2026, an estimated $5.02M.
  • Medtronic made up 0.7% of JB Capital's portfolio in Q1 2026, its #33 holding.
  • JB Capital first reported a position in Medtronic in Q3 2022 and has held it in 15 quarters since.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on JB Capital's 13F filing for Q1 2026, filed 27 Apr 2026.